Form D · Other Health Care
SeromYx Systems, Inc.
Boston, MA · CIK 0001783382
Offering snapshot reported Jul 24, 2019 · SEC filing
- Reported sold
- $3.12M Offering amount: $3.12M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $125K Reported outside-investor minimum
- First sale
- Jul 11, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 24, 2019 | Initial | $3,115,000 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-344993
Source: Form D, filed Jul 24, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Galit Alter | Executive, Promoter |
| Kenneth J. Kelley | Director, Promoter |
| Corinne Luedemann | Executive |
| Lewis J. Miller | Director |
| Todd Suscovich | Executive, Promoter |
| Piers Whitehead | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3 Larchmont St
Boston, MA, 02124
Boston, MA, 02124